<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Disulfiram</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00822</strong>&#160; (APRD00767)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00822/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00822/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00822.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00822.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00822.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00822.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00822.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00822">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>1,1'-dithiobis(N,N-diethylthioformamide)</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>N,N,N',N'-tetraethylthiuram disulfide</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Tetraethylthioperoxydicarbonic Diamide</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Tetraethylthiuram Disulfide</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Tetraethylthiuram Disulphide</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Antabus</td><td>Actavis</td></tr><tr><td>Antabuse</td><td>Actavis</td></tr><tr><td>Antaethyl</td><td>Sanofi</td></tr><tr><td>Antalcol</td><td>Sintofarm</td></tr><tr><td>Anticol</td><td>Polfa Warszawa</td></tr><tr><td>Antietanol</td><td>Sanofi</td></tr><tr><td>Chronol</td><td>Charoon Bhesaj</td></tr><tr><td>Esperal</td><td>Sanofi</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/enzyme-inhibitors">Enzyme Inhibitors</a></li>
<li><a href="/mesh/alcohol-deterrents">Alcohol Deterrents</a></li></ul></td></tr><tr><th>CAS number</th><td>97-77-8</td></tr><tr><th>Weight</th><td>Average: 296.539<br>Monoisotopic: 296.05093141</td></tr><tr><th>Chemical Formula</th><td>C<sub>10</sub>H<sub>20</sub>N<sub>2</sub>S<sub>4</sub></td></tr><tr><th>InChI Key</th><td>AUZONCFQVSMFAP-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">N,N-diethyl[(diethylcarbamothioyl)disulfanyl]carbothioamide</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CCN(CC)C(=S)SSC(=S)N(CC)CC</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00822.gif?1265922773">show</a>(8.65 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organosulfur Compounds</td></tr><tr><th>Class</th><td>Thiocarbonyl Compounds</td></tr><tr><th>Subclass</th><td>Organic Thiocarbonic Acid Derivatives</td></tr><tr><th>Direct parent</th><td>Organic Thiocarbonic Acid Derivatives</td></tr><tr><th>Alternative parents</th><td>Tertiary Amines; Organic Disulfides; Polyamines</td></tr><tr><th>Substituents</th><td>polyamine; amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the organic thiocarbonic acid derivatives. These are organic compounds containing the thiocarbonic acid structure or a derivative thereof.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment and management of chronic alcoholism</td></tr><tr><th>Pharmacodynamics</th><td>Disulfiram produces a sensitivity to alcohol which results in a highly unpleasant reaction when the patient under treatment ingests even small amounts of alcohol. Disulfiram blocks the oxidation of alcohol at the acetaldehyde stage during alcohol metabolism following disulfiram intake, the concentration of acetaldehyde occurring in the blood may be 5 to 10 times higher than that found during metabolism of the same amount of alcohol alone. Accumulation of acetaldehyde in the blood produces a complex of highly unpleasant symptoms referred to hereinafter as the disulfiram-alcohol reaction. This reaction, which is proportional to the dosage of both disulfiram and alcohol, will persist as long as alcohol is being metabolized. Disulfiram does not appear to influence the rate of alcohol elimination from the body. Prolonged administration of disulfiram does not produce tolerance; the longer a patient remains on therapy, the more exquisitely sensitive he becomes to alcohol.</td></tr><tr><th>Mechanism of action</th><td>Disulfiram blocks the oxidation of alcohol at the acetaldehyde stage during alcohol metabolism following disulfiram intake causing an accumulation of acetaldehyde in the blood producing highly unpleasant symptoms. Disulfiram blocks the oxidation of alcohol through its irreversible inactivation of aldehyde dehydrogenase, which acts in the second step of ethanol utilization. In addition, disulfiram competitively binds and inhibits the peripheral benzodiazepine receptor, which may indicate some value in the treatment of the symptoms of alcohol withdrawal, however this activity has not been extensively studied.</td></tr><tr><th>Absorption</th><td>Disulfiram is absorbed slowly from the gastrointestinal tract (80 to 90% of oral dose).</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic.</p></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>LD<sub>50</sub>=8.6g/kg (orally in rats). Symptoms of overdose include irritation, slight drowsiness, unpleasant taste, mild GI disturbances, and orthostatic hypotension.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th></tr></thead><tbody><tr><td>Disulfiram Action Pathway</td><td>Drug action</td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9808</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9668</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.548</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.71</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8236</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9884</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8379</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8497</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.7558</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Inhibitor</td>
        <td>0.9106</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Inhibitor</td>
        <td>0.8948</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9231</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Inhibitor</td>
        <td>0.8994</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Inhibitor</td>
        <td>0.796</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>High CYP Inhibitory Promiscuity</td>
        <td>0.5397</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9132
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Carcinogens  
        </td>
        <td>
            0.6989
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9767
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.7419 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8617
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8823
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Odyssey pharmaceuticals inc</li>
<li>Par pharmaceutical inc</li>
<li>Watson laboratories inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.duramed.ca">Duramed</a></li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li>Pharmacy Service Center</li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.pliva.com">Pliva Inc.</a></li>
<li><a href="http://www.worldoftest.com">Qualitest</a></li>
<li><a href="http://www.spectrumpharm.com">Spectrum Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01418">Acenocoumarol</a></td><td>Disulfiram may increase the anticoagulant effect of acenocoumarol.</td></tr><tr><td><a href="/drugs/DB01223">Aminophylline</a></td><td>Disulfiram may increase the effect and toxicity of aminophylline.</td></tr><tr><td><a href="/drugs/DB00701">Amprenavir</a></td><td>Increased irsk of side effects (oral solution)</td></tr><tr><td><a href="/drugs/DB01125">Anisindione</a></td><td>Disulfiram may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00356">Chlorzoxazone</a></td><td>Disulfiram may increase the serum level of chlorzoxazone by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of chlorzoxazone if diltiazem is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00907">Cocaine</a></td><td>Increases the cardiac toxicity of cocaine</td></tr><tr><td><a href="/drugs/DB00266">Dicoumarol</a></td><td>Disulfiram may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB00651">Dyphylline</a></td><td>Increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00754">Ethotoin</a></td><td>Increases the effect of phenytoin</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>Disulfiram may increase the effect of fosphenytoin.</td></tr><tr><td><a href="/drugs/DB00951">Isoniazid</a></td><td>Increased risk of CNS adverse effects</td></tr><tr><td><a href="/drugs/DB00532">Mephenytoin</a></td><td>Increases the effect of phenytoin</td></tr><tr><td><a href="/drugs/DB00916">Metronidazole</a></td><td>Possible acute psychosis and confusion</td></tr><tr><td><a href="/drugs/DB01303">Oxtriphylline</a></td><td>Disulfiram may increase the effect and toxicity of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>Disulfiram may increase the therapeutic and adverse effects of phenytoin.</td></tr><tr><td><a href="/drugs/DB00277">Theophylline</a></td><td>Disulfiram may increase the effect and toxicity of theophylline.</td></tr><tr><td><a href="/drugs/DB00932">Tipranavir</a></td><td>Disulfiram may cause Tipranavir (Aptivus brand) toxicity by inhibiting alcohol metabolism. Aptivus capsules contain alcohol.  </td></tr><tr><td><a href="/drugs/DB00347">Trimethadione</a></td><td>Disulfiram, a strong CYP2E1 inhibitor, may decrease the metabolism and clearance of Trimethadione, a CYP2E1 substrate. Consider alternate therapy or monitor for changes in Trimethadione therapeutic and adverse effects if Disulfiram is initiated, discontinued or dose changed. </td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>Disulfiram may increase the anticoagulant effect of warfarin.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid alcohol for up to 14 days after treatment has been stopped.</li>
<li>Take without regard to meals.</li></ul></td></tr></tbody></table>